Adage Capital Management, L.P. - Sep 30, 2025 SCHEDULE 13G/A Report for BridgeBio Oncology Therapeutics, Inc. Common Stock, par value $0.0001 per share (BBOT)

Filing Manager
Adage Capital Management, L.P.
Reporting Manager
Adage Capital Management, L.P.
Security
BridgeBio Oncology Therapeutics, Inc. Common Stock, par value $0.0001 per share
Symbol
BBOT
Shares outstanding
79.1M shares
Disclosed Ownership
1.49M shares
Ownership
1.88%
Form type
SCHEDULE 13G/A
Date filed
11/13/2025, 09:02 AM
Date of event
Sep 30, 2025
SEC
View on sec.gov

Reporting Managers (3)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Adage Capital Management, L.P. 1.88% 1.49M 0 1.49M /s/ Robert Atchinson By: Adage Capital Partners LLC, its General Partner, By: Robert Atchinson, its Managing Member
Robert Atchinson 1.88% 1.49M 0 1.49M /s/ Robert Atchinson Robert Atchinson, individually
Phillip Gross 1.88% 1.49M 0 1.49M /s/ Phillip Gross Phillip Gross, individually